Medtronic’s Guardian Connect Continuous Glucometer with Predictive Capabilities Approved by FDA

The FDA granted Medtronic its approval for the Guardian Connect continuous glucose monitor. It’s intended for diabetes patients between 14 and 75 years of age that tend to get multiple daily insulin injections.

A small wireless device, the Guardian Sensor 3, is attached to the skin, which takes regular blood samples to test for sugar levels (Read more...)

Full Story →